The remaining differences can also be explained quite simply: for example, the greater need for anemia patients, by the fact that not only is the intrinsic factor switched off, but their ability for passive diffusion is diminished
The clinical literature reports typical adult dosing ranges and FDA-approved labeling exists where applicable, yet translating those into a personal dose is a clinical task, not a chart lookup
The safety profile of retatrutide in TRANSCEND-T2D-1 was generally consistent with the GLP-1 receptor agonist class
Other recognised side effects include injection site reactions, fatigue, and increased heart rate (reported as 'uncommon', affecting less than 1 in 100 people)
Because the medication is injected subcutaneously, its absorption is not affected by the contents of your stomach, though eating a very heavy meal right before your dose may increase the risk of digestive discomfort